Blockade of 5-HT2ARs, a defining pharmacological feature of atypical antipsychotics, has been linked to elevated hippocampal BDNF levels [441] correlating with improvements in the cognitive and negative symptoms of schizophrenia [442]. The gene discussed is BDNF; the disease is schizophrenia.